Back to ROIV
FARALLON CAPITAL MANAGEMENT, L.L.C. → ROIV
FARALLON CAPITAL MANAGEMENT, L.L.C. ROIV Position History
Roivant Sciences Ltd. • Healthcare
Quarters held
15
Latest value
$506.4M
Q2 2026
Peak value
$506.4M
First seen
Q2 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2023 | $23.7M |
| Q3 2023 | $45M |
| Q4 2023 | $82.4M |
| Q1 2024 | $9.5M |
| Q1 2024 | $9.5M |
| Q2 2024 | $7.1M |
| Q3 2024 | $427K |
| Q4 2024 | $438K |
| Q1 2025 | $373K |
| Q2 2025 | $417K |
| Q3 2025 | $560K |
| Q3 2025 | $560K |
| Q4 2025 | $803K |
| Q1 2026 | $268M |
| Q2 2026 | $506.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $506.4M | 14.31M | — | — |
| Q1 2026 | $268M | 9.68M | — | — |
| Q4 2025 | $803K | 37.0K | — | — |
| Q3 2025 | $560K | 37.0K | — | — |
| Q3 2025 | $560K | 37.0K | — | — |
| Q2 2025 | $417K | 37.0K | — | — |
| Q1 2025 | $373K | 37.0K | — | — |
| Q4 2024 | $438K | 37.0K | — | — |
| Q3 2024 | $427K | 37.0K | — | — |
| Q2 2024 | $7.1M | 673.0K | — | — |
| Q1 2024 | $9.5M | 898.6K | — | — |
| Q1 2024 | $9.5M | 898.6K | — | — |
| Q4 2023 | $82.4M | 7.34M | — | — |
| Q3 2023 | $45M | 3.85M | — | — |
| Q2 2023 | $23.7M | 2.35M | — | — |
Other funds holding ROIV
$1.2B
$1.2B
$857.7M
$841.4M
$758.4M